The National Institutes of Health unveiled two new grant programs this week for small research companies that will be supported by stimulus funds provided to the NIH under the American Recovery & Reinvestment Act of 2009. “These new programs will help provide much-needed resources to biotech companies, who are at the cusp of many medical [...]
Filed under: BIO, Uncategorized | Tagged: BIO, financing, NIH, Small Business | Leave a Comment »
Stories are appearing nationally that highlight the importance of SBIR funding in partnership with venture capital dollars on local economies. These investment capital/government funding partnerships can foster growth in the biotech industry. This is the best way to ensure that our scientists are able to develop cutting-edge treatments and therapies and bring them to the [...]
Filed under: BIO, Congress, In the News, SBIR, venture capital | Tagged: BIO, biotech, Kansas City, Kansas Enterprise Technology Corp, Rep. Graves, SBIR, Senate, Senator Bond | Leave a Comment »
In St. Louis, another small biotech firm is contemplating what steps to take if the SBIR bill is not renewed soon. Currently, Kereos Inc., a 15-employee company studying promising new methods of detecting and treating cancer is excluded from the SBIR program. This piece in Sunday’s St. Louis Post Dispatch illustrates the struggles that many [...]
Filed under: BIO, Congress, In the News, SBIR, venture capital | Tagged: BIO, biotech, House Small Business Committee, Mark Heesen, SBIR, Senate, VC | Leave a Comment »
The Senate Small Business Committee has passed an SBIR reauthorization bill. We hope the House and Senate will work together to pass a final reauthorization bill before this program is set to expire on September 30, 2008.
From the Puget Sound Business Journal:
Under a compromise negotiated in the U.S. Senate, small companies that are majority-owned [...]
Filed under: BIO, Congress, In the News, SBIR, venture capital | Tagged: BIO, Biotechnology industry, Jim Greenwood, NIH, SBA, SBIR, Senate Small Business Committee, VC, vc-owned firms | 1 Comment »
Both Forbes and East Coast Blogging mentions that people can now apply for the $6 million in biotechnology tax credits in Maryland. They didn’t discuss how enthusiastic the Maryland Biotech community is over this new plan.
There is a lot of growing excitement over Governor O’Malley’s BIO 2020 Initiative. Today, the Baltimore [...]
Filed under: BIO | Tagged: Baltimore, BIO, biotech, Forbes, Gov. OMalley, MD | Leave a Comment »
Here at BIO, we are rethinking our online strategy and we can’t do it without you. Help us provide you with the best online information, tools and resources possible and…..
Take our survey!
Filed under: BIO | Tagged: BIO | Leave a Comment »
House Small Business Committee Holds Hearing on the Reauthorization of the Small Business Innovation Research Program
Witness List
March 13, 2008
Chairwoman Velazquez’s (NY-12) led a lively hearing on the SBIR program in helping small businesses support promising research. She emphasized the importance of reinstating eligibility of majority venture capital-backed companies and highlighted the remedy offered in the [...]
Filed under: Congress, SBIR | Tagged: BIO, Congress, SBIR, venture capital | Leave a Comment »
